Macrolides protect against Pseudomonas aeruginosa infection via inhibition of inflammasomes. (Q40144933)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

title

Macrolides protect against Pseudomonas aeruginosa infection via inhibition of inflammasomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference

Pseudomonas aeruginosa

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Augustine M K Choi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Li-Chao Fan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Jie-Lu Lin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Jia-Wei Yang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Bei Mao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Hai-Wen Lu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Bao-Xue Ge

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

publication date

6 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Lung Cellular and Molecular Physiology

24 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

volume

313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

page(s)

L677-L686

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?

24 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

A novel pathway for inducible nitric-oxide synthase activation through inflammasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Activation of inflammasome signaling mediates pathology of acute P. aeruginosa pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Mitochondrial ROS potentiates indirect activation of the AIM2 inflammasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Implication of Interleukin (IL)-18 in the pathogenesis of chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Role of the inflammasome-caspase1/11-IL-1/18 axis in cigarette smoke driven airway inflammation: an insight into the pathogenesis of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Critical role for Ipaf in Pseudomonas aeruginosa-induced caspase-1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Cigarette smoke destabilizes NLRP3 protein by promoting its ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Nonantibiotic macrolides restore airway macrophage phagocytic function with potential anti-inflammatory effects in chronic lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

NAIPs: building an innate immune barrier against bacterial pathogens. NAIPs function as sensors that initiate innate immunity by detection of bacterial proteins in the host cell cytosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Role of inflammasome activation in development and exacerbation of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Differential requirements for NAIP5 in activation of the NLRC4 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Activation of the Nlrp3 inflammasome by mitochondrial reactive oxygen species: a novel mechanism of albumin-induced tubulointerstitial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Reactive oxygen species regulate caspase-11 expression and activation of the non-canonical NLRP3 inflammasome during enteric pathogen infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Flagellin-induced NLRC4 phosphorylation primes the inflammasome for activation by NAIP5

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Pseudomonas aeruginosa activates caspase 1 through Ipaf

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Distribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Auranofin protects against anthrax lethal toxin-induced activation of the Nlrp1b inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Inflammatory caspases are innate immune receptors for intracellular LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Elevated expression of the NLRP3 inflammasome in neutrophilic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Inflammasome-mediated IL-1β production in humans with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Mitochondrial Regulation of Inflammasome Activation in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

Ginsenoside Rg3 regulates S-nitrosylation of the NLRP3 inflammasome via suppression of iNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

The role of azithromycin in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00123.2017

10.1152/AJPLUNG.00123.2017

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28684545%20AND%20SRC:MED&resulttype=core&format=json